Peptide Purity Testing: What an HPLC Purity Result Means

Research Use Only. This article summarizes published analytical chemistry literature and FDA guidance on how synthetic peptide purity is measured and reported. It is not medical advice. Vital Tides materials are intended for controlled laboratory and analytical research only—not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Peptide purity testing usually means reversed-phase HPLC with UV detection near 214 nm. The column separates a sample into peaks, and software then divides the main peak’s area by the total peak area. So a 99% result means 99% of the detected signal came from the main peak. It does not mean 99% of the vial’s weight.

This guide walks through how the test works and what the number leaves out. It also covers common impurities and the FDA impurity thresholds revised in July 2026. Our peptide Research page collects related literature summaries.

How peptide purity testing works with HPLC

High-performance liquid chromatography (HPLC) separates molecules as they travel through a packed column. In reversed-phase HPLC, the column surface is hydrophobic. Meanwhile, a gradient of water and acetonitrile carries the sample through it.

A typical purity run follows four steps:

1. Sample preparation. The analyst dissolves a small portion of the sample in a suitable solvent.
2. Separation. Each component leaves the column at its own retention time, based mostly on hydrophobicity.
3. Detection. A UV detector reads absorbance, often at 214–220 nm, where the peptide bond absorbs.
4. Integration. Software measures each peak’s area. Purity equals the main peak area divided by the total area, times 100.

Here is a simple illustration with made-up numbers:

Peak	Area (arbitrary units)	Share of total
Main peptide	9,850	98.5%
Impurity A	90	0.9%
Impurity B	60	0.6%
Total	10,000	100%

In this example, the report would read 98.5% purity. Still, that figure only covers what eluted and absorbed at the chosen wavelength.

What does peptide purity mean on a report?

A purity percentage is relative, not absolute. In other words, it compares detected signals with each other. That design creates three blind spots.

Unequal UV response. Kuipers and Gruppen measured UV absorbance at 214 nm for each amino acid (PMID 17539659). The peptide bond scored 923 M⁻¹cm⁻¹.

By contrast, tryptophan absorbed about 30 times more than a peptide bond. Phenylalanine, tyrosine, and histidine absorbed about six times more. As a result, an impurity with a different composition can look larger or smaller than its true share.

Co-elution. If an impurity exits the column with the main peak, it counts as product. For this reason, FDA’s Q2(R2) guidance links specificity to the resolution of the two closest-eluting components (FDA Q2(R2), March 2024). It also recommends combining two or more procedures when one cannot separate everything.

Invisible material. Finally, anything that does not absorb at the chosen wavelength drops out of the math.

Peptide purity vs. net peptide content

Purity and quantity answer different questions. Synthetic peptides usually come as salts with bound water.

For example, Roux et al. noted that solid-phase synthesis and purification mainly yield peptides with trifluoroacetic acid present (PMID 18035848). Cationic peptides then form trifluoroacetate salts. Moreover, the authors described this counter-ion as tightly bound in the peptide they studied.

Counter-ions and water add mass. However, they do not enter the area-percent calculation. So a sample can show high HPLC purity and still contain notable non-peptide mass.

Measurement	Question it answers	Common methods	What it does not show
HPLC purity	What share of the detected signal is the main peak?	RP-HPLC with UV detection	Total peptide mass, water, or salt content
Net peptide content	What share of the total mass is peptide?	Amino acid analysis or nitrogen analysis	Which peptides are present
Assay (content)	How much target compound does the sample hold?	Quantitation against a reference standard	Related impurities, unless reported separately

Common impurities found by peptide purity testing

D’Hondt et al. reviewed peptide-related impurities in peptide medicines (PMID 25044089). Most peptides today come from solid-phase peptide synthesis (SPPS). Accordingly, the review groups impurities by origin.

Synthesis-related impurities:

• Deletion sequences, linked to inefficient Fmoc deprotection
• Insertion sequences, linked to excess amino acid reagents
• Diastereomers from racemization of amino acid residues
• Adducts left by incomplete side-chain deprotection
• Oxidized side chains, dimers, and oligomers
• Unwanted counter-ions such as trifluoroacetate
• Cross-contamination with unrelated peptides

Degradation-related impurities:

• β-elimination products
• Diketopiperazine and pyroglutamate formation
• Succinimide formation

Many of these differ from the target by one residue or one modification. Because of that, they often elute close to the main peak. The review also warns that such impurities can skew early functional studies.

How regulators set impurity thresholds

Peptide quality rules are not fully uniform. In 2009, Vergote et al. found that compendial peptide specifications were barely harmonized. They also reported large differences between the European Pharmacopoeia and the United States Pharmacopeia (PMID 19750489).

In the U.S., the newest signal came on July 28, 2026. That day, FDA published 17 revised draft product-specific guidances (PSGs) for generic peptide products (FDA announcement). It also withdrew its May 2021 synthetic peptide ANDA guidance, saying it no longer reflected current scientific thinking.

For example, the July 2026 draft semaglutide PSG lists these impurity recommendations (FDA draft PSG):

• Report each related impurity above 0.1% of the drug substance.
• Identify each related impurity above 0.5%.
• Common impurities should not exceed the reference product’s level or 1.0%, whichever is greater.
• New impurities call for efforts to bring them below 1.0%.

Keep the context in view, though. These are draft, nonbinding recommendations for generic drug applications. Research-use materials are not drug products. Even so, the thresholds show how finely regulators track individual impurities.

How to read a purity result on a certificate of analysis

A certificate of analysis (COA) is a lab report for one sample. Therefore, check these fields before relying on the purity figure:

• Sample or lot ID that matches the material in hand
• Method, such as HPLC, ideally with the detection wavelength
• Chromatogram, so the peaks behind the number are visible
• Specification and result, for instance “> 98.0%” and the measured value
• System suitability, which shows the instrument ran consistently
• Lab name and dates for receipt and reporting

Also note the scope. A purity result does not cover moisture, counter-ions, or microbial attributes. Those need their own methods.

Vital Tides runs purity testing on its research peptides. Published purity reports appear on the Vital Tides certifications page. For a compound example, see the retatrutide research peptide page.

Limits of a single purity number

Even a clean peptide purity testing report describes one sample, one method, and one date. In addition, keep these limits in mind:

• Method dependence. A different column, gradient, or wavelength can shift the result.
• Response factors. UV signal per molecule varies with composition, as noted above.
• Stability. Degradation pathways such as succinimide formation can change a sample over time.
• Scope. Purity data do not explain how a compound acts in a study model.

Mechanism questions need separate literature. For instance, our tesamorelin mechanism of action review covers receptor science rather than analytical chemistry.

Conclusion: peptide purity testing in brief

Peptide purity testing by HPLC reports the main peak’s share of the detected UV signal. It does not report total peptide mass, water, or counter-ion content. Meanwhile, related impurities from synthesis and degradation often elute close to the main peak.

Overall, read any purity figure alongside its method, chromatogram, and sample ID. In generic drug reviews, FDA now asks for impurities above 0.1% to be reported. So a headline percentage is only the start.

FAQ